1. Home
  2. UVSP vs PVLA Comparison

UVSP vs PVLA Comparison

Compare UVSP & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Univest Financial Corporation

UVSP

Univest Financial Corporation

HOLD

Current Price

$34.68

Market Cap

910.5M

Sector

Finance

ML Signal

HOLD

Logo Palvella Therapeutics Inc.

PVLA

Palvella Therapeutics Inc.

HOLD

Current Price

$97.56

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UVSP
PVLA
Founded
1876
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
910.5M
1.1B
IPO Year
1989
N/A

Fundamental Metrics

Financial Performance
Metric
UVSP
PVLA
Price
$34.68
$97.56
Analyst Decision
Hold
Strong Buy
Analyst Count
3
16
Target Price
$33.00
$124.25
AVG Volume (30 Days)
141.6K
259.5K
Earning Date
01-21-2026
11-11-2025
Dividend Yield
2.52%
N/A
EPS Growth
19.65
N/A
EPS
2.98
N/A
Revenue
$309,144,000.00
N/A
Revenue This Year
$12.98
N/A
Revenue Next Year
$3.02
N/A
P/E Ratio
$11.71
N/A
Revenue Growth
7.22
N/A
52 Week Low
$22.83
$11.17
52 Week High
$35.65
$106.71

Technical Indicators

Market Signals
Indicator
UVSP
PVLA
Relative Strength Index (RSI) 70.03 56.83
Support Level $34.20 $84.25
Resistance Level $35.65 $112.00
Average True Range (ATR) 0.85 7.60
MACD 0.18 -1.03
Stochastic Oscillator 77.62 50.25

Price Performance

Historical Comparison
UVSP
PVLA

About UVSP Univest Financial Corporation

Univest Financial Corp is engaged in domestic banking services for individuals, businesses, municipalities and non-profit organizations. The bank has three operating segments; Banking segment provides financial services including a full range of banking services such as deposit taking, loan origination, and servicing, mortgage banking, other general banking services, and equipment lease financing, Wealth Management segment offers investment advisory, financial planning, trust and brokerage services, and The Insurance segment includes a full-service insurance brokerage agency offering commercial property and casualty insurance, employee benefits solutions, personal insurance lines and human resources consulting. It generates majority of its revenue from the banking segment.

About PVLA Palvella Therapeutics Inc.

Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.

Share on Social Networks: